In the BioHarmony Drug Report Database

"Preview" Icon

Niacin

Niaspan, Niaspan Titration Starter Pack, Wampocap (niacin) is a small molecule pharmaceutical. Niacin was first approved as Niaspan on 1982-01-01. It is used to treat hypercholesterolemia, hypertriglyceridemia, pellagra, and peripheral vascular diseases in the USA. It is known to target hydroxycarboxylic acid receptor 3, hydroxycarboxylic acid receptor 2, hydroxycarboxylic acid receptor 1, and carbonic anhydrase 2.

 

Trade Name

 

Niaspan, Niaspan Titration Starter Pack, Wampocap
 

Common Name

 

niacin
 

ChEMBL ID

 

CHEMBL573
 

Indication

 

hypercholesterolemia, hypertriglyceridemia, pellagra, peripheral vascular diseases
 

Drug Class

 

Image (chem structure or protein)

Niacin structure rendering